Meeting
2019 ASCO Annual Meeting
ALINA: A phase III study of alectinib versus chemotherapy as adjuvant therapy in patients with stage IB–IIIA anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer (NSCLC).
Authors
Benjamin J. Solomon
Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
Benjamin J. Solomon , Jin Seok Ahn , Fabrice Barlesi , Rafal Dziadziuszko , Makoto Nishio , Alice Tsang Shaw , Walter Bordogna , Christoph Meyenberg , Yi-Long Wu
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Adjuvant Therapy
Clinical Trial Registration Number
NCT03456076
Citation
J Clin Oncol 37, 2019 (suppl; abstr TPS8569)
DOI
10.1200/JCO.2019.37.15_suppl.TPS8569
Abstract #
TPS8569
Poster Bd #
325a
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
A phase III trial to compare atezolizumab (atezo) vs best supportive care (BSC) following adjuvant chemotherapy in patients (pts) with completely resected NSCLC: IMpower010.
First Author: Heather A. Wakelee
Poster
2011 ASCO Annual Meeting
Interim report of on-study demographics and toxicity from E1505, a phase III randomized trial of adjuvant (adj) chemotherapy (chemo) with or without bevacizumab (B) for completely resected early-stage non-small cell lung cancer (NSCLC).
First Author: H. A. Wakelee
Poster
2023 ASCO Annual Meeting
A randomized, double blinded, multicenter phase 3 study of platinum-based chemotherapy with or without QL1706 as adjuvant therapy in completely resected stage II-IIIb NSCLC.
First Author: Yuming Zhu
Poster
2019 ASCO Annual Meeting
ORION: A Phase 2, randomized, multicenter, double-blind study to assess efficacy and safety of durvalumab+olaparib vs durvalumab alone as maintenance therapy in Stage IV non-small cell lung cancer (NSCLC).
First Author: Myung-Ju Ahn